Laurence DELHAES

November 2024 European Respiratory Journal

Fungal lung disease

Authors : Tavleen Kaur Jaggi, Ritesh Agarwal, Pei Yee Tiew, Anand Shah, Emily C. Lydon, Chadi A. Hage, Grant W. Waterer, Charles R. Langelier, Laurence Delhaes, Sanjay H. Chotirmall

September 2023 Microorganisms

The Molecular Identification and Antifungal Susceptibility of Clinical Isolates of Aspergillus Section Flavi from Three French Hospitals

Authors : Elie Djenontin, Jean-Marc Costa, Bita Mousavi, Lin Do Ngoc Nguyen, Jacques Guillot, Laurence Delhaes, Françoise Botterel, Eric Dannaoui

December 2022 Journal of Clinical Medicine

Interest of a Commercialized Pneumocystis jirovecii Quantitative PCR to Discriminate Colonization from Pneumocystis Pneumonia according to the Revised EORTC/MSGERC Criteria

Authors : Florian Lussac-Sorton, Tara Fleur, Thibault Voisin, Nahéma Issa, Élodie Blanchard, Éléna Charpentier, Laurence Delhaes

August 2021 Journal of Clinical Medicine

New Insights in Microbial Species Predicting Lung Function Decline in CF: Lessons from the MucoFong Project

Authors : Florence Francis, Raphael Enaud, Perrine Soret, Florian Lussac-Sorton, Marta Avalos-Fernandez, Stéphanie Bui, Michael Fayon, Rodolphe Thiébaut, Laurence Delhaes

February 2021 Journal of Allergy and Clinical Immunology

Reply

Authors : Louise-Eva Vandenborght, Raphaël Enaud, Charlotte Urien, Noémie Coron, Pierre-Olivier Girodet, Stéphanie Ferreira, Patrick Berger, Laurence Delhaes

December 2020 Scientific Reports

Respiratory mycobiome and suggestion of inter-kingdom network during acute pulmonary exacerbation in cystic fibrosis

Authors :

September 2020 Frontiers in cellular and infection microbiology

Pneumocystis jirovecii in Patients With Cystic Fibrosis: A Review.

Authors :

September 2020 Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Sputum versus nasopharyngeal samples for the molecular diagnosis of respiratory viral infection in cystic fibrosis: A pilot study.

Authors :

September 2020 The Journal of allergy and clinical immunology

Type 2-high asthma is associated with a specific indoor mycobiome and microbiome.

Authors :

May 2020 Travel Medicine and Infectious Disease

Severe toxoplasmosis imported from tropical Africa in immunocompetent patients: A case series

Authors :

December 2019 Mycoses

A European ECMM‐ESCMID survey on goals and practices for mycobiota characterisation using next‐generation sequencing

Authors :

December 2019 Clinical Microbiology and Infection

Multicentre study to determine the Etest epidemiological cut-off values of antifungal drugs in Candida spp. and Aspergillus fumigatus species complex

Authors :

July 2019 Journal of Cystic Fibrosis

CT evaluation of hyperattenuating mucus to diagnose allergic bronchopulmonary aspergillosis in the special condition of cystic fibrosis

Authors :

May 2019 Journal of Clinical Medicine

Intestinal Inflammation in Children with Cystic Fibrosis Is Associated with Crohn’s-Like Microbiota Disturbances

Authors :

March 2019 Journal of Cystic Fibrosis

Prevalence, geographic risk factor, and development of a standardized protocol for fungal isolation in cystic fibrosis: Results from the international prospective study “MFIP”

Authors :

March 2019 The Lung Microbiome

From culturomics to metagenomics: the mycobiome in chronic respiratory diseases

Authors :

June 2018 Parasitology

Genetic diversity and evolution ofPneumocystisfungi infecting wild Southeast Asian murid rodents

Authors :

April 2018 Medical Mycology

Developing collaborative works for faster progress on fungal respiratory infections in cystic fibrosis

Authors :

February 2018 Mycopathologia

Toward the Standardization of Mycological Examination of Sputum Samples in Cystic Fibrosis: Results from a French Multicenter Prospective Study

Authors :

February 2018 Mycopathologia

Fungal and Bacterial Diversity of Airway Microbiota in Adults with Cystic Fibrosis: Concordance Between Conventional Methods and Ultra-Deep Sequencing, and Their Practical use in the Clinical Laboratory

Authors :

December 2017 Antimicrobial Agents and Chemotherapy

Plasmodium falciparum Recrudescence Two Years after Treatment of an Uncomplicated Infection without Return to an Area Where Malaria Is Endemic

Authors :

December 2017 Frontiers in Immunology

Protective Microbiota: From Localized to Long-Reaching Co-Immunity

Authors :

October 2017 Radiology

Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis: MR Imaging of Airway Mucus Contrasts as a Tool for Diagnosis

Authors :

December 2016 PLOS ONE

Effects of Propidium Monoazide (PMA) Treatment on Mycobiome and Bacteriome Analysis of Cystic Fibrosis Airways during Exacerbation

Authors :

May 2015 Journal of Clinical Microbiology

Molecular Diagnosis of Toxoplasmosis in Immunocompromised Patients: a 3-Year Multicenter Retrospective Study

Authors :

Members

Laurence DELHAES

Publications 25

Fungal lung disease

The Molecular Identification and Antifungal Susceptibility of Clinical Isolates of Aspergillus Section Flavi from Three French Hospitals

Interest of a Commercialized Pneumocystis jirovecii Quantitative PCR to Discriminate Colonization from Pneumocystis Pneumonia according to the Revised EORTC/MSGERC Criteria

New Insights in Microbial Species Predicting Lung Function Decline in CF: Lessons from the MucoFong Project

Reply

Respiratory mycobiome and suggestion of inter-kingdom network during acute pulmonary exacerbation in cystic fibrosis

Pneumocystis jirovecii in Patients With Cystic Fibrosis: A Review.

Sputum versus nasopharyngeal samples for the molecular diagnosis of respiratory viral infection in cystic fibrosis: A pilot study.

Type 2-high asthma is associated with a specific indoor mycobiome and microbiome.

Severe toxoplasmosis imported from tropical Africa in immunocompetent patients: A case series

A European ECMM‐ESCMID survey on goals and practices for mycobiota characterisation using next‐generation sequencing

Multicentre study to determine the Etest epidemiological cut-off values of antifungal drugs in Candida spp. and Aspergillus fumigatus species complex

CT evaluation of hyperattenuating mucus to diagnose allergic bronchopulmonary aspergillosis in the special condition of cystic fibrosis

Intestinal Inflammation in Children with Cystic Fibrosis Is Associated with Crohn’s-Like Microbiota Disturbances

Prevalence, geographic risk factor, and development of a standardized protocol for fungal isolation in cystic fibrosis: Results from the international prospective study “MFIP”

From culturomics to metagenomics: the mycobiome in chronic respiratory diseases

Genetic diversity and evolution ofPneumocystisfungi infecting wild Southeast Asian murid rodents

Developing collaborative works for faster progress on fungal respiratory infections in cystic fibrosis

Toward the Standardization of Mycological Examination of Sputum Samples in Cystic Fibrosis: Results from a French Multicenter Prospective Study

Fungal and Bacterial Diversity of Airway Microbiota in Adults with Cystic Fibrosis: Concordance Between Conventional Methods and Ultra-Deep Sequencing, and Their Practical use in the Clinical Laboratory

Plasmodium falciparum Recrudescence Two Years after Treatment of an Uncomplicated Infection without Return to an Area Where Malaria Is Endemic

Protective Microbiota: From Localized to Long-Reaching Co-Immunity

Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis: MR Imaging of Airway Mucus Contrasts as a Tool for Diagnosis

Effects of Propidium Monoazide (PMA) Treatment on Mycobiome and Bacteriome Analysis of Cystic Fibrosis Airways during Exacerbation

Molecular Diagnosis of Toxoplasmosis in Immunocompromised Patients: a 3-Year Multicenter Retrospective Study

Team

Bronchial remodeling